LEXINGTON, Mass., Feb. 17, 2022 iSpecimen Inc. , an online marketplace for human biospecimens, today reported its financial results for the three and twelve-month periods ended December 31,. | February 17, 2022
/PRNewswire/ NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for.
Chinese Partner, 3D Medicines, Expects to Initiate Trial in Second Half of 2022 in Patients with Hematological Malignancies Who Achieved Objective Response.